<html><head><title>2024-03-22</title><link rel="stylesheet" type="text/css" href="static/table.css"/></head><body><table id="container">
  <thead>
    <tr style="text-align: right;">
      <th role="columnheader">No.</th>
      <th role="columnheader">capSize</th>
      <th role="columnheader">stock</th>
      <th role="columnheader">chance</th>
      <th role="columnheader">risk</th>
      <th role="columnheader">tags</th>
      <th role="columnheader">Volatility</th>
      <th role="columnheader">YTD%</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>1</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/BBD">BBD<br>Banco Bradesco</a></td>
      <td>1. Banco Bradesco SA is a well-established financial and insurance services provider with a strong presence in Latin America<br>2. The company operates in the banking and insurance segments, offering a wide range of financial products and services<br>3. Latin American stocks and currencies have been on the rise, indicating a positive market outlook for companies like Banco Bradesco SA<br>4. The new CEO of Bradesco, Marcelo Noronha, sees potential for public offerings in Brazil next year, driven by falling interest rates in the US and stronger growth in Brazil<br>5. The company recently announced a dividend payment, reflecting a commitment to rewarding shareholders</td>
      <td>1. Latin American economies have faced challenges such as high inflation and restricted monetary policies, which could impact the financial sector<br>2. Caution about the timing of US interest rate cuts may affect the performance of Latin American stocks and currencies<br>3. The market scenario in Latin America is labeled 'absolutely challenging' by the outgoing CEO of Bradesco, indicating potential obstacles for the company</td>
      <td>Financial Services<br>Latin America<br>Dividend Stocks<br>Regional Market Outlook</td>
      <td>323.06</td>
      <td>-13.46</td>
    </tr>
    <tr>
      <td>2</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/SLB">SLB<br>Schlumberger</a></td>
      <td>1. The recent trading session showed a positive move for Schlumberger (SLB), indicating potential for upward movement in the stock price.<br>2. De-risking the Welchau play in Austria may ease Europe's energy crisis, indicating positive impact on Schlumberger's operations in the region.<br>3. Artisan Partners’ investor letter highlighted significant surge in US stocks, which can be a positive indicator for Schlumberger.<br>4. One small company strategically investing in natural gas projects in Europe can enhance energy security, potentially benefiting Schlumberger’s operations.<br>5. The average brokerage recommendation for Schlumberger is equivalent to a Buy, indicating positive sentiment from Wall Street analysts.</td>
      <td>1. The overly optimistic recommendations of Wall Street analysts may make the effectiveness of the average brokerage recommendation questionable.<br>2. Oil and gas stock trading can be volatile and inconsistent, so potential investors need to be cautious.<br>3. US Treasury yields and global economic factors can impact the energy sector, presenting risks for Schlumberger.<br>4. The company’s operations in Austria and Europe may be subject to geopolitical and regulatory risks, impacting its performance.</td>
      <td>Energy<br>Stock Analysis<br>Investment<br>Oil and Gas<br>Market Trends</td>
      <td>459.24</td>
      <td>-35.75</td>
    </tr>
    <tr>
      <td>3</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/NCLH">NCLH<br>Norwegian Cruise Line</a></td>
      <td>1. Norwegian Cruise Line Holdings Ltd. has shown rising price performance, earning an upgrade to its IBD Relative Strength Rating.<br>2. Oceania Cruises, a brand under NCLH, has announced the appointment of its two executive culinary directors, indicating a focus on enhancing customer experience and quality.<br>3. Goldman Sachs sees smooth sailing ahead for cruise stocks, initiating coverage of Royal Caribbean and Carnival with optimistic price targets.</td>
      <td>1. The stock closed with a -1.07% move from the prior day, indicating potential volatility in the market.<br>2. The company has reported declined visitation and tepid performance in its fiscal results.<br>3. The cruise industry may face uncertainty due to global events or market changes.</td>
      <td>Cruise industry<br>Stock performance<br>Company news<br>Market volatility<br>Customer experience</td>
      <td>313.07</td>
      <td>16.77</td>
    </tr>
    <tr>
      <td>4</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/LU">LU<br>Lufax Holding</a></td>
      <td>1. Lufax Holding Ltd is a leading financial services enabler for small business owners in China<br>2. The company's technology-empowered personal financial services platform offers personal lending and wealth management solutions<br>3. Lufax Holding's significant public companies ownership suggests that the key decisions are influenced by major stakeholders</td>
      <td>1. Lufax Holding received a notice from the New York Stock Exchange indicating that it is below the NYSE's continued listing standards<br>2. The company's ADS trading price is a concern for the NYSE's listing standards</td>
      <td>Financial Services<br>China<br>NYSE<br>Technology<br>Investments</td>
      <td>398.70</td>
      <td>90.31</td>
    </tr>
    <tr>
      <td>5</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/CBAY">CBAY<br>CymaBay Therapeutics</a></td>
      <td>1. CymaBay Therapeutics, Inc. has shown strong potential in the biopharmaceutical industry with its focus on innovative therapies for liver and other chronic diseases.<br>2. The company's seladelpar has received Marketing Authorization Application (MAA) validation, and its recent acceptance by the U.S. FDA for priority review indicates a positive outlook for the stock.<br>3. The proposed acquisition by Gilead Sciences, Inc. for $4.3 billion would further boost the company's valuation and market presence.</td>
      <td>1. The pending acquisition by Gilead Sciences, Inc. may lead to uncertainties in the stock's performance and future strategic direction.<br>2. Regulatory challenges and competition in the biopharmaceutical industry pose potential risks for CymaBay Therapeutics, Inc.<br>3. Earnings and revenue surprises, as well as insider selling, may impact short-term stock performance.</td>
      <td>biopharmaceutical<br>innovative therapies<br>acquisition<br>regulatory challenges<br>market presence</td>
      <td>1492.20</td>
      <td>39.04</td>
    </tr>
    <tr>
      <td>6</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/LYFT">LYFT<br>Lyft</a></td>
      <td>1. Shares of ride sharing service Lyft jumped 5.4% in the afternoon session after major indices rose<br>2. LYFT is set to thrive in the growing rideshare market, buoyed by competitive pricing and cost-cutting measures<br>3. On the surface level, ridesharing service provider Lyft seems like an attractive, undervalued alternative to sector king Uber<br>4. With the economy on a recovery trek, the smaller competitor could ride coattails</td>
      <td>1. The company's liquidity position raises major concerns<br>2. Lyft and Uber have said they will halt operations in Minneapolis because of a new city ordinance that increase wages for app-based drivers<br>3. If broader conditions become squeezed, the ridesharing industry could become commoditized</td>
      <td>Rideshare Market<br>Competitive Pricing<br>Liquidity Concerns<br>App-Based Driver Wages<br>Commoditization Risk</td>
      <td>473.78</td>
      <td>52.02</td>
    </tr>
    <tr>
      <td>7</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/HOOD">HOOD<br>Robinhood Markets</a></td>
      <td>1. Shares of financial services company Robinhood (NASDAQ:HOOD) jumped 7.3% in the afternoon session after major indices rose, with the S&P 500 up 0.8% while the Nasdaq gained 1.2%, as the Federal Open Market Committee left the policy rate unchanged at 5.25-5.50% during its March 2024 meeting.<br>2. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is focused on providing retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading.</td>
      <td>1. The U.S. Department of Justice and 15 states sued Apple alleging that company monopolized the smartphone market, which may raise concerns about similar antitrust actions against other big tech companies including Robinhood.<br>2. The strong of new highs in cryptocurrency prices and spot bitcoin ETFs is rooted in the industry's historic step forward, but it also indicates a high level of volatility and potential regulatory scrutiny.</td>
      <td>Stock Analysis<br>Investing<br>Finance<br>Tech<br>Antitrust</td>
      <td>378.99</td>
      <td>57.25</td>
    </tr>
    <tr>
      <td>8</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/DAL">DAL<br>Delta Air Lines</a></td>
      <td>1. Strong air travel demand and shareholder-friendly actions bode well for Delta Air Lines (DAL).<br>2. Passenger demand is steadily recovering post-COVID, in both the leisure and business segments.<br>3. Reductions in general inflationary pressures, and the prospect of lower interest rates, are helping to offset likely permanent increases in labor and maintenance costs.<br>4. Airline stocks were soaring, with Delta Air Lines experiencing a +0.74% change compared to its last close.</td>
      <td>1. High costs and technological glitches pose challenges for Delta Air Lines.<br>2. Consolidation has neither resulted in less competition nor made it easier for existing carriers to survive.<br>3. Selective stocks will benefit from easing cost pressures and margin improvements later this year.<br>4. Qantas Airways is increasing the price of accessing its network of lounges by as much as 17%.</td>
      <td>Airline Industry<br>Travel Demand<br>Cost Pressures<br>Stock Performance<br>Competition</td>
      <td>310.97</td>
      <td>9.50</td>
    </tr>
    <tr>
      <td>9</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/DIS">DIS<br>nan</a></td>
      <td>1. ISS's endorsement of Nelson Peltz's bid for a board seat indicates a possible shift in Disney's governance and decision-making process.<br>2. The support of influential proxy advisors and business leaders for Nelson Peltz suggests potential future changes in Disney's direction and strategy.</td>
      <td>1. The proxy battle for a board seat could lead to internal conflicts and disruptions within Disney's leadership.<br>2. Investor activism may introduce uncertainty and volatility in Disney's stock and operations.</td>
      <td>Investor Activism<br>Governance Change<br>Proxy Battle<br>Corporate Strategy<br>Leadership Disruption</td>
      <td>370.20</td>
      <td>30.70</td>
    </tr>
    <tr>
      <td>10</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/AZN">AZN<br>AstraZeneca</a></td>
      <td>1. AstraZeneca's acquisition of Fusion Biopharma for $21 per share in cash, along with a contingent value right of $3 per share, indicates strategic growth and expansion in the pharmaceutical industry.<br>2. GSK's plan to lower the prices of its inhaled respiratory products to $35 per month in the US in 2025 could lead to increased market share and customer loyalty.<br>3. The cap on out-of-pocket costs for GSK's asthma and COPD medicines in the US may result in improved access to essential medications for eligible patients and could positively impact the company's reputation.<br>4. Nvidia's unveiling of the highly anticipated Blackwell chip and Super Micro's filing to sell 2 million common shares may signal potential growth in the semiconductor industry.</td>
      <td>1. The failure of Merck's combination cancer drugs in a late-stage study raises concerns about the company's research and development efforts and could impact its stock performance.<br>2. AstraZeneca's previous trial failures with the combination of Keytruda and Lynparza highlight potential challenges in its partnership strategies and drug development pipeline.<br>3. US lawmakers' investigation into inhaler prices could lead to regulatory actions that may affect the profitability of AstraZeneca and other manufacturers.<br>4. The split of Unilever's ice cream business and the resulting job cuts may have implications for the company's overall financial performance and market position.</td>
      <td>pharmaceutical industry<br>acquisition<br>drug development<br>regulatory scrutiny<br>market performance</td>
      <td>336.14</td>
      <td>-3.53</td>
    </tr>
    <tr>
      <td>11</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/PARA">PARA<br>nan</a></td>
      <td>1. Paramount Global (PARA) has witnessed a jump in share price and strong trading volume, suggesting potential upside.<br>2. The company has received multiple acquisition offers, indicating strong interest from potential buyers.</td>
      <td>1. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road, signaling potential risks for future performance.</td>
      <td>Media and Entertainment<br>Acquisition Target<br>Stock Performance<br>Earnings Estimate<br>Takeover Interest</td>
      <td>294.86</td>
      <td>-15.99</td>
    </tr>
    <tr>
      <td>12</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/ALIT">ALIT<br>nan</a></td>
      <td>1. Alight Inc has signed a significant agreement to sell its Professional Services segment and its Payroll & HCM Outsourcing businesses, which could result in a positive financial impact.<br>2. The company has been making strategic moves to strengthen its technology and enhance competitiveness, as stated by CEO Stephan Scholl.<br>3. The recent upgrade to a Zacks Rank #2 reflects growing optimism about the company's earnings prospects and may drive the stock higher in the near term.</td>
      <td>1. The CEO of Alight Inc sold a significant number of shares, which could raise concerns about insider confidence and potential impact on stock performance.<br>2. While the company is at a 52-week high, there may be uncertainty about sustaining or surpassing these gains in the future.<br>3. The sale of two units within its Payroll & Professional Services business may impact the company's overall operations and strategic direction.</td>
      <td>cloud-based technology<br>business solutions<br>financial performance<br>competitiveness<br>insider selling</td>
      <td>309.29</td>
      <td>19.86</td>
    </tr>
    <tr>
      <td>13</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/DOC">DOC<br>nan</a></td>
      <td>1. Healthpeak Properties, Inc. has closed its merger with Physicians Realty Trust, positioning itself well to capitalize on industry trends.<br>2. The company's revenue and EPS for the quarter ended December 2023 show positive growth, indicating a strong performance.<br>3. Acquisition of Physicians Realty Trust will enhance Healthpeak's position in the market and lead to potential growth opportunities.<br>4. Continued growth in revenue, along with the upcoming merger, suggests a positive outlook for the stock.</td>
      <td>1. The company needs to carefully manage the integration process of the merger to avoid any potential challenges.<br>2. The impact of the merger on financials and operations should be closely monitored for any potential risks.<br>3. Market volatility and regulatory changes in the healthcare real estate sector could pose risks to the company's performance.<br>4. Revenue and growth projections post-merger need to be monitored for potential deviations from estimates.</td>
      <td>Real Estate<br>Healthcare<br>Merger<br>Revenue Growth<br>Market Trends</td>
      <td>680.85</td>
      <td>-9.41</td>
    </tr>
    <tr>
      <td>14</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/MRVI">MRVI<br>Maravai LifeSciences</a></td>
      <td>1. Maravai LifeSciences has reported strong gains in the mid-cap segment, fueled by confidence about an economic soft landing and a dovish flip by the Fed.</td>
      <td>1. Full year revenue has declined as the company adjusts to post-pandemic demand, indicating potential challenges in the current market environment.</td>
      <td>Life Sciences<br>Biotech<br>Mid-cap stocks<br>Earnings report<br>Market performance</td>
      <td>824.41</td>
      <td>20.00</td>
    </tr>
    <tr>
      <td>15</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/META">META<br>Meta Platforms</a></td>
      <td>1. Meta Platforms, Inc. is a leading developer of social media applications, with a strong focus on technology that connects people, builds communities, and supports businesses.<br>2. The company operates through two segments, the Family of Apps and Reality Labs, indicating a diverse portfolio of offerings.<br>3. Despite recent issues such as outages and legal challenges, Meta Platforms continues to play a prominent role in the social media landscape.</td>
      <td>1. Recent insider selling by Chief Legal Officer Jennifer Newstead may raise concerns about confidence in the company.<br>2. Ongoing legal challenges, such as the class action lawsuit by advertisers, could potentially impact Meta Platforms financially and reputationally.<br>3. Competition from other social media platforms, such as Reddit, and potential regulatory challenges, particularly in international markets like China, pose risks to the company.</td>
      <td>Social Media<br>Technology<br>Legal Challenges<br>Competition<br>Regulatory Risk</td>
      <td>344.97</td>
      <td>37.24</td>
    </tr>
    <tr>
      <td>16</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/SWN">SWN<br>nan</a></td>
      <td>1. Southwestern Energy's higher oil production and reduction in marketing purchases bode well for its future performance.<br>2. The longer-term bull case for natural gas, which is the primary focus of Southwestern Energy's operations, rests on expanding U.S. exports.</td>
      <td>1. The stock price of Southwestern Energy is sensitive to the significantly high institutional ownership, which may lead to volatility based on their actions.<br>2. While the company delivered impressive earnings and revenue surprises, the broader macroeconomic environment could still impact its future performance.</td>
      <td>Energy<br>Oil & Gas<br>Earnings Report<br>Market Sensitivity<br>Export Potential</td>
      <td>373.96</td>
      <td>5.81</td>
    </tr>
    <tr>
      <td>17</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/FNMA">FNMA<br>nan</a></td>
      <td>1. Fannie Mae CEO Priscilla Almodovar believes in the importance of homeownership and its impact on people's lives.Strong employment numbers and hotter-than-expected inflation data may keep mortgage rates higher for longer, according to Fannie Mae.Consumer sentiment toward housing and homebuying sentiment have increased, indicating potential positive trends in the housing market.</td>
      <td>1. Fannie Mae now says mortgage rates will stay above 6% through 2025, indicating a potential challenge for homebuyers and the housing market.The increase in mortgage rates in February has driven a modest downgrade to expectations for total home sales and mortgage originations in 2024, according to the Fannie Mae Economic and Strategic Research Group.U.S. economy is growing, unemployment is low, and corporate revenues are up, but these indicators spell trouble for the housing sector, suggesting potential risks for Fannie Mae.</td>
      <td>Housing Market<br>Mortgage Rates<br>Homeownership<br>Consumer Sentiment<br>Economic Indicators</td>
      <td>451.23</td>
      <td>95.00</td>
    </tr>
    <tr>
      <td>18</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/SNAP">SNAP<br>Snap</a></td>
      <td>1. Snap Inc. continues to attract attention as it closes at $11.16 in the latest trading session, marking a slight -0.36% move from the previous day.<br>2. The company's co-founder and CEO's statement on potential profits following the tech company's public launch indicates an optimistic outlook for its future performance.<br>3. Snap Inc.'s CFO recently sold a significant number of shares, which may signal a lack of confidence in the company's growth potential.<br>4. The potential impact of a possible ban on TikTok in China on foreign investment highlights the interconnectedness of social media platforms and global economic dynamics.</td>
      <td>1. Snap Inc.'s stock price closed at $11.19, reflecting a -1.76% drop from the previous trading session, indicating potential volatility and uncertainty in the stock's performance.<br>2. The company's decision to repurchase its IP from Fit Finder could indicate a lack of growth opportunities in the augmented reality sector, posing a potential challenge to its long-term business strategy.<br>3. Ongoing legal and regulatory issues, such as the US Supreme Court case concerning social media platforms and the pressure to censor inaccurate posts, may impact Snap Inc.'s operations and market reputation.<br>4. The House of Representatives' vote to potentially force TikTok's parent company ByteDance to divest could lead to heightened competition and strategic challenges for Snap Inc. in the social media market.</td>
      <td>Social Media<br>Stock Performance<br>Investor Confidence<br>Regulatory Challenges<br>Competition</td>
      <td>459.24</td>
      <td>-35.75</td>
    </tr>
  </tbody>
</table><script src="static/tablesort.min.js"></script><script src="static/tablesort.number.min.js"></script><script>new Tablesort(document.getElementById("container"));</script></body></html>